{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:50:46Z","timestamp":1794844246410,"version":"4.9.1"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) predominantly occurs as a late onset (LOAD) form involving neurodegeneration and cognitive decline with progressive memory loss. Risk factors that include aging promote accumulation of AD pathologies, such as amyloid-beta and tau aggregates, as well as inflammation and oxidative stress. Homeostatic glial states regulate and suppress pathology buildup; inflammatory states exacerbate pathology by releasing pro-inflammatory cytokines. Multiple stresses likely induce glial senescence, which could decrease supportive functions and reinforce inflammation. In this perspective, we hypothesize that aging first drives AD pathology burden, whereafter AD pathology putatively induces glial senescence in LOAD. We hypothesize that increasing glial senescence, particularly local senescent microglia accumulation, sustains and drives perpetuating buildup and spread of AD pathologies, glial aging, and further\u00a0senescence. We predict that increasing glial senescence, particularly local senescent microglia accumulation, also transitions individuals from healthy cognition into mild cognitive impairment and LOAD diagnosis. These pathophysiological underpinnings may centrally contribute to LOAD onset, but require further mechanistic investigation.<\/jats:p>","DOI":"10.1038\/s41467-023-37304-3","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T13:02:54Z","timestamp":1679749374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":166,"title":["An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-2073","authenticated-orcid":false,"given":"Victor","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Ramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-9626","authenticated-orcid":false,"given":"Marie-\u00c8ve","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"key":"37304_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure, M. A. & Dickson, D. W. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol. Neurodegener. 14, 32 (2019).","journal-title":"Mol. Neurodegener."},{"key":"37304_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies, E. & Trushina, E. Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. J. Alzheimers Dis. 57, 1105 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"37304_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long, J. M. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312\u2013339 (2019).","journal-title":"Cell"},{"key":"37304_CR4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1017\/S1092852900016886","volume":"13","author":"HJ Milionis","year":"2008","unstructured":"Milionis, H. J., Florentin, M. & Giannopoulos, S. Metabolic syndrome and Alzheimer\u2019s disease: a link to a vascular hypothesis? CNS Spectr. 13, 606\u2013613 (2008).","journal-title":"CNS Spectr."},{"key":"37304_CR5","first-page":"00119","volume":"S0166-2236","author":"A Guerrero","year":"2021","unstructured":"Guerrero, A., De Strooper, B. & Arancibia-C\u00e1rcamo, I. L. Cellular senescence at the crossroads of inflammation and Alzheimer\u2019s disease. Trends Neurosci. S0166-2236, 00119\u20133 (2021).","journal-title":"Trends Neurosci."},{"key":"37304_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41583-020-0325-z","volume":"21","author":"S Saez-Atienzar","year":"2020","unstructured":"Saez-Atienzar, S. & Masliah, E. Cellular senescence and Alzheimer disease: the egg and the chicken scenario. Nat. Rev. Neurosci. 21, 433\u2013444 (2020).","journal-title":"Nat. Rev. Neurosci."},{"key":"37304_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis, V. et al. Cellular senescence: defining a path forward. Cell 179, 813\u2013827 (2019).","journal-title":"Cell"},{"key":"37304_CR8","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.3233\/JAD-161221","volume":"60","author":"E Fielder","year":"2017","unstructured":"Fielder, E., von Zglinicki, T. & Jurk, D. The DNA damage response in neurons: die by apoptosis or survive in a senescence-like state? J. Alzheimers Dis. 60, S107\u2013S131 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"37304_CR9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/emboj.2011.492","volume":"31","author":"A Barascu","year":"2012","unstructured":"Barascu, A. et al. Oxidative stress induces an ATM-independent senescence pathway through p38 MAPK-mediated lamin B1 accumulation. EMBO J. 31, 1080\u20131094 (2012).","journal-title":"EMBO J."},{"key":"37304_CR10","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta, J. C. et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15, 978\u2013990 (2013).","journal-title":"Nat. Cell Biol."},{"key":"37304_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molmed.2010.03.003","volume":"16","author":"A Freund","year":"2010","unstructured":"Freund, A., Orjalo, A. V., Desprez, P.-Y. & Campisi, J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 16, 238 (2010).","journal-title":"Trends Mol. Med."},{"key":"37304_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1196\/annals.1297.063","volume":"1019","author":"DW Killilea","year":"2004","unstructured":"Killilea, D. W., Wong, S. L., Cahaya, H. S., Atamna, H. & Ames, B. N. Iron accumulation during cellular senescence. Ann. N.Y. Acad. Sci. 1019, 365\u2013367 (2004).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"37304_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.redox.2017.08.015","volume":"14","author":"S Masaldan","year":"2018","unstructured":"Masaldan, S. et al. Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox Biol. 14, 100\u2013115 (2018). Reinforcing our prediction that dystrophic microglia are senescent due to their ferritin enrichment, Masaldan et al. (2018) demonstrate that among different iron storage proteins, senescent cells feature lysosomal dysfunction that selectively induces ferritin buildup and subsequent iron accumulation.","journal-title":"Redox Biol."},{"key":"37304_CR14","doi-asserted-by":"publisher","first-page":"E4612","DOI":"10.1073\/pnas.1705499114","volume":"114","author":"H Yang","year":"2017","unstructured":"Yang, H., Wang, H., Ren, J., Chen, Q. & Chen, Z. J. cGAS is essential for cellular senescence. Proc. Natl. Acad. Sci. U.S.A. 114, E4612 (2017).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"37304_CR15","doi-asserted-by":"crossref","unstructured":"Ogrodnik, M. et al. Whole\u2010body senescent cell clearance alleviates age\u2010related brain inflammation and cognitive impairment in mice. Aging Cell 20, e13296 (2021). Ogrodnik et al. (2021) demonstrate that systemic administration of two different senolytics improves spatial memory in p16INK4A-overexpressing aged mice, while also decreasing SASP factors expression and brain inflammation relevant to senescent cells.","DOI":"10.1111\/acel.13296"},{"key":"37304_CR16","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41591-018-0092-9","volume":"24","author":"M Xu","year":"2018","unstructured":"Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246 (2018).","journal-title":"Nat. Med."},{"key":"37304_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33226-8","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Rejuvenation of the aged brain immune cell landscape in mice through p16-positive senescent cell clearance. Nat. Commun. 13, 5671 (2022).","journal-title":"Nat. Commun."},{"key":"37304_CR18","doi-asserted-by":"publisher","unstructured":"Fulop, T. et al. Immunosenescence and Alzheimer\u2019s Disease. in Healthy Longevity and Immune System (eds. Bueno, V. & Pawelec, G.) 177\u2013199 (Springer International Publishing, 2022). https:\/\/doi.org\/10.1007\/978-3-030-87532-9_9.","DOI":"10.1007\/978-3-030-87532-9_9"},{"key":"37304_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fncel.2020.00129","volume":"14","author":"CC Walton","year":"2020","unstructured":"Walton, C. C., Begelman, D., Nguyen, W. & Andersen, J. K. Senescence as an amyloid cascade: the amyloid senescence hypothesis. Front. Cell. Neurosci. 14, 129 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"37304_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/rej.2006.9096","volume":"10","author":"BE Flanary","year":"2007","unstructured":"Flanary, B. E., Sammons, N. W., Nguyen, C., Walker, D. & Streit, W. J. Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res. 10, 61\u201374 (2007).","journal-title":"Rejuvenation Res."},{"key":"37304_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori, I. et al. Oxidative stress, aging, and diseases. Clin. Interv. Aging 13, 757 (2018).","journal-title":"Clin. Interv. Aging"},{"key":"37304_CR22","doi-asserted-by":"publisher","first-page":"M924","DOI":"10.1093\/gerona\/59.9.M924","volume":"59","author":"JE Morley","year":"2004","unstructured":"Morley, J. E. & Baumgartner, R. N. Cytokine-related aging process. J. Gerontol. Ser. A 59, M924\u2013M929 (2004).","journal-title":"J. Gerontol. Ser. A"},{"key":"37304_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.cdd.4401528","volume":"12","author":"H Kadowaki","year":"2005","unstructured":"Kadowaki, H. et al. Amyloid \u03b2 induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ. 12, 19\u201324 (2005).","journal-title":"Cell Death Differ."},{"key":"37304_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrn3710","volume":"15","author":"GC Brown","year":"2014","unstructured":"Brown, G. C. & Neher, J. J. Microglial phagocytosis of live neurons. Nat. Rev. Neurosci. 15, 209\u2013216 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"37304_CR25","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/jnc.15327","volume":"158","author":"CA Butler","year":"2021","unstructured":"Butler, C. A. et al. Microglial phagocytosis of neurons in neurodegeneration, and its regulation. J. Neurochem. 158, 621\u2013639 (2021). Butler et al. (2021) provide a comprehensive overview as to how microglia remove synaptic elements and perform phagoptosis of neurons, via detailing multiple mechanisms involving microglial receptors and downstream pathways.","journal-title":"J. Neurochem."},{"key":"37304_CR26","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","volume":"109","author":"CL Hsieh","year":"2009","unstructured":"Hsieh, C. L. et al. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J. Neurochem. 109, 1144 (2009).","journal-title":"J. Neurochem."},{"key":"37304_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.redox.2016.09.001","volume":"10","author":"G Testa","year":"2016","unstructured":"Testa, G. et al. Changes in brain oxysterols at different stages of Alzheimer\u2019s disease: their involvement in neuroinflammation. Redox Biol. 10, 24 (2016).","journal-title":"Redox Biol."},{"key":"37304_CR28","doi-asserted-by":"crossref","unstructured":"Gamba, P. et al. Oxidized cholesterol as the driving force behind the development of Alzheimer\u2019s disease. Front. Aging Neurosci. 7, (2015).","DOI":"10.3389\/fnagi.2015.00119"},{"key":"37304_CR29","doi-asserted-by":"crossref","unstructured":"Song, L., Pei, L., Yao, S., Wu, Y. & Shang, Y. NLRP3 inflammasome in neurological diseases, from functions to therapies. Front. Cell. Neurosci. 11, 63 (2017).","DOI":"10.3389\/fncel.2017.00063"},{"key":"37304_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1126\/science.aat0473","volume":"362","author":"NJ Allen","year":"2018","unstructured":"Allen, N. J. & Lyons, D. A. Glia as architects of central nervous system formation and function. Science 362, 181 (2018).","journal-title":"Science"},{"key":"37304_CR31","doi-asserted-by":"crossref","unstructured":"Chesser, A., Pritchard, S. & Johnson, G. Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease. Front. Neurol. 4, 122 (2013).","DOI":"10.3389\/fneur.2013.00122"},{"key":"37304_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","volume":"20","author":"S-S Yoon","year":"2012","unstructured":"Yoon, S.-S. & Jo, S. A. Mechanisms of amyloid-\u03b2 peptide clearance: potential therapeutic targets for Alzheimer\u2019s disease. Biomol. Ther. 20, 245\u2013255 (2012).","journal-title":"Biomol. Ther."},{"key":"37304_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1439-x","volume":"17","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. NG2 glia regulate brain innate immunity via TGF-\u03b22\/TGFBR2 axis. BMC Med. 17, 204 (2019).","journal-title":"BMC Med."},{"key":"37304_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/glia.23721","volume":"68","author":"Y Liu","year":"2020","unstructured":"Liu, Y. & Aguzzi, A. NG2 glia are required for maintaining microglia homeostatic state. Glia 68, 345\u2013355 (2020).","journal-title":"Glia"},{"key":"37304_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbi.2013.12.018","volume":"37","author":"JE Tichauer","year":"2014","unstructured":"Tichauer, J. E. et al. Age-dependent changes on TGF\u03b21 Smad3 pathway modify the pattern of microglial cell activation. Brain. Behav. Immun. 37, 187 (2014).","journal-title":"Brain. Behav. Immun."},{"key":"37304_CR36","doi-asserted-by":"publisher","first-page":"e0227887","DOI":"10.1371\/journal.pone.0227887","volume":"15","author":"C Limbad","year":"2020","unstructured":"Limbad, C. et al. Astrocyte senescence promotes glutamate toxicity in cortical neurons. PLOS ONE 15, e0227887 (2020).","journal-title":"PLOS ONE"},{"key":"37304_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57663-x","volume":"10","author":"CM Willis","year":"2020","unstructured":"Willis, C. M. et al. Astrocyte support for oligodendrocyte differentiation can be conveyed via extracellular vesicles but diminishes with age. Sci. Rep. 10, 828 (2020).","journal-title":"Sci. Rep."},{"key":"37304_CR38","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/cdd.2016.37","volume":"23","author":"C Turnquist","year":"2016","unstructured":"Turnquist, C. et al. p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration. Cell Death Differ 23, 1515\u20131528 (2016).","journal-title":"Cell Death Differ"},{"key":"37304_CR39","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model. Nat. Neurosci. 22, 719\u2013728 (2019).","journal-title":"Nat. Neurosci."},{"key":"37304_CR40","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi, Y. et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J. Exp. Med. 216, 2546\u20132561 (2019). By demonstrating that microglia are more responsible in driving APOE and tauopathy-mediated neurodegeneration in the PS19 mouse model, Shi et al. (2019) reinforce that microglia may be more important than astrocytes in advancing hp-tau pathology in LOAD.","journal-title":"J. Exp. Med."},{"key":"37304_CR41","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","volume":"595","author":"CS McAlpine","year":"2021","unstructured":"McAlpine, C. S. et al. Astrocytic interleukin-3 programs microglia and limits Alzheimer\u2019s disease. Nature 595, 701\u2013706 (2021).","journal-title":"Nature"},{"key":"37304_CR42","doi-asserted-by":"publisher","first-page":"e105380","DOI":"10.15252\/embj.2020105380","volume":"39","author":"N Scott-Hewitt","year":"2020","unstructured":"Scott-Hewitt, N. et al. Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia. EMBO J. 39, e105380 (2020).","journal-title":"EMBO J."},{"key":"37304_CR43","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. TREM2 lipid sensing sustains microglia response in an Alzheimer\u2019s disease model. Cell 160, 1061 (2015).","journal-title":"Cell"},{"key":"37304_CR44","doi-asserted-by":"publisher","first-page":"26043","DOI":"10.1074\/jbc.M115.679043","volume":"290","author":"Y Atagi","year":"2015","unstructured":"Atagi, Y. et al. Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J. Biol. Chem. 290, 26043 (2015).","journal-title":"J. Biol. Chem."},{"key":"37304_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43535-6","volume":"9","author":"K Shirotani","year":"2019","unstructured":"Shirotani, K. et al. Aminophospholipids are signal-transducing TREM2 ligands on apoptotic cells. Sci. Rep. 9, 7508 (2019).","journal-title":"Sci. Rep."},{"key":"37304_CR46","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. TREM2 is a receptor for \u03b2-amyloid which mediates microglial function. Neuron 97, 1023 (2018).","journal-title":"Neuron"},{"key":"37304_CR47","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat. Immunol. 22, 586\u2013594 (2021).","journal-title":"Nat. Immunol."},{"key":"37304_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2009.2","volume":"1","author":"JJ Rodr\u00edguez","year":"2010","unstructured":"Rodr\u00edguez, J. J., Witton, J., Olabarria, M., Noristani, H. N. & Verkhratsky, A. Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer\u2019s disease. Cell Death Dis. 1, e1 (2010).","journal-title":"Cell Death Dis."},{"key":"37304_CR49","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas, C. et al. Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease. Nature 552, 355\u2013361 (2017).","journal-title":"Nature"},{"key":"37304_CR50","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising, C. et al. NLRP3 inflammasome activation drives tau pathology. Nature 575, 669 (2019).","journal-title":"Nature"},{"key":"37304_CR51","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3233\/JAD-170634","volume":"60","author":"ME Ahmed","year":"2017","unstructured":"Ahmed, M. E. et al. Co-localization of glia maturation factor with NLRP3 inflammasome and autophagosome markers in human Alzheimer\u2019s disease brain. J. Alzheimers Dis. 60, 1143 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"37304_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-022-01370-3","volume":"10","author":"RN Taddei","year":"2022","unstructured":"Taddei, R. N. et al. Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages. Acta Neuropathol. Commun. 10, 72 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"37304_CR53","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/npp.2016.185","volume":"42","author":"A Niraula","year":"2017","unstructured":"Niraula, A., Sheridan, J. F. & Godbout, J. P. Microglia priming with aging and stress. Neuropsychopharmacology 42, 318 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"37304_CR54","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-981-13-9913-8_8","volume":"1175","author":"A Verkhratsky","year":"2019","unstructured":"Verkhratsky, A., Zorec, R., Rodriguez-Arellano, J. J. & Parpura, V. Neuroglia in ageing. Adv. Exp. Med. Biol 1175, 181 (2019).","journal-title":"Adv. Exp. Med. Biol"},{"key":"37304_CR55","doi-asserted-by":"publisher","first-page":"eaaw6404","DOI":"10.1126\/sciadv.aaw6404","volume":"5","author":"S Wegmann","year":"2019","unstructured":"Wegmann, S. et al. Experimental evidence for the age dependence of tau protein spread in the brain. Sci. Adv. 5, eaaw6404 (2019).","journal-title":"Sci. Adv."},{"key":"37304_CR56","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-018-0543-y","volume":"562","author":"TJ Bussian","year":"2018","unstructured":"Bussian, T. J. et al. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562, 578\u2013582 (2018). Bussian et al. (2018) demonstrate that the PS19 mouse model, solely overexpressing human hp-tau, leads to senescent microglia and astrocyte buildup that can be targeted with senolytics to prevent cognitive decline.","journal-title":"Nature"},{"key":"37304_CR57","doi-asserted-by":"publisher","first-page":"733945","DOI":"10.3389\/fcell.2021.733945","volume":"9","author":"Y-Y Xie","year":"2021","unstructured":"Xie, Y.-Y. et al. Clemastine ameliorates myelin deficits via preventing senescence of oligodendrocytes precursor cells in Alzheimer\u2019s disease model mouse. Front. Cell Dev. Biol. 9, 733945 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"37304_CR58","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5114\/aoms.2018.76863","volume":"16","author":"E Papu\u0107","year":"2018","unstructured":"Papu\u0107, E. & Rejdak, K. The role of myelin damage in Alzheimer\u2019s disease pathology. Arch. Med. Sci. 16, 345\u2013351 (2018).","journal-title":"Arch. Med. Sci."},{"key":"37304_CR59","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fncel.2020.575082","volume":"14","author":"I Chacon-De-La-Rocha","year":"2020","unstructured":"Chacon-De-La-Rocha, I. et al. Accelerated dystrophy and decay of oligodendrocyte precursor cells in the APP\/PS1 model of Alzheimer\u2019s-Like pathology. Front. Cell. Neurosci. 14, 383 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"37304_CR60","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1073\/pnas.1818348116","volume":"116","author":"AM Nicaise","year":"2019","unstructured":"Nicaise, A. M. et al. Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis. Proc. Natl. Acad. Sci. 116, 9030\u20139039 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"37304_CR61","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.cmet.2019.09.001","volume":"30","author":"S Lautrup","year":"2019","unstructured":"Lautrup, S., Sinclair, D. A., Mattson, M. P. & Fang, E. F. NAD+ in brain aging and neurodegenerative disorders. Cell Metab. 30, 630\u2013655 (2019).","journal-title":"Cell Metab."},{"key":"37304_CR62","doi-asserted-by":"publisher","first-page":"e2011226118","DOI":"10.1073\/pnas.2011226118","volume":"118","author":"Y Hou","year":"2021","unstructured":"Hou, Y. et al. NAD+ supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer\u2019s disease via cGAS\u2013STING. Proc. Natl. Acad. Sci. 118, e2011226118 (2021). Complementing our hypothesis that LOAD is an aging disease later leading into glial senescence accumulation, Hou et al. (2021) demonstrate that aging trajectory interventions reduce inflammation, minimize senescence buildup of multiple brain cell types (including microglia), and improve spatial memory in APP-PS1 mice overexpressing amyloid-beta.","journal-title":"Proc. Natl. Acad. Sci."},{"key":"37304_CR63","doi-asserted-by":"crossref","unstructured":"Bhat, R. et al. Astrocyte senescence as a component of Alzheimer\u2019s disease. PLoS One 7, e45069 (2012).","DOI":"10.1371\/journal.pone.0045069"},{"key":"37304_CR64","doi-asserted-by":"publisher","first-page":"109419","DOI":"10.1016\/j.celrep.2021.109419","volume":"36","author":"S Gaikwad","year":"2021","unstructured":"Gaikwad, S. et al. Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer\u2019s disease and frontotemporal dementia. Cell Rep. 36, 109419 (2021).","journal-title":"Cell Rep."},{"key":"37304_CR65","doi-asserted-by":"crossref","unstructured":"Han, X., Zhang, T., Liu, H., Mi, Y. & Gou, X. Astrocyte senescence and alzheimer\u2019s disease: a review. Front. Aging Neurosci. 12, 148 (2020).","DOI":"10.3389\/fnagi.2020.00148"},{"key":"37304_CR66","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/glia.23790","volume":"68","author":"P Raghunatha","year":"2020","unstructured":"Raghunatha, P., Vosoughi, A., Kauppinen, T. M. & Jackson, M. F. Microglial NMDA receptors drive pro-inflammatory responses via PARP-1\/TRMP2 signaling. Glia 68, 1421\u20131434 (2020).","journal-title":"Glia"},{"key":"37304_CR67","doi-asserted-by":"crossref","unstructured":"Rouillard, M. E. et al. The cellular senescence factor extracellular HMGB1 directly inhibits oligodendrocyte progenitor cell differentiation and impairs CNS remyelination. Front. Cell. Neurosci. 16, 833186 (2022).","DOI":"10.3389\/fncel.2022.833186"},{"key":"37304_CR68","doi-asserted-by":"publisher","first-page":"108398","DOI":"10.1016\/j.celrep.2020.108398","volume":"33","author":"JE Rexach","year":"2020","unstructured":"Rexach, J. E. et al. Tau pathology drives dementia risk-associated gene networks toward chronic inflammatory states and immunosuppression. Cell Rep 33, 108398 (2020).","journal-title":"Cell Rep"},{"key":"37304_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26851-2","volume":"12","author":"M Jin","year":"2021","unstructured":"Jin, M. et al. Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation. Nat. Commun. 12, 6565 (2021).","journal-title":"Nat. Commun."},{"key":"37304_CR70","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.stem.2022.06.007","volume":"29","author":"M Jin","year":"2022","unstructured":"Jin, M. et al. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer\u2019s disease. Cell Stem Cell 29, 1135\u20131153.e8 (2022). Jin et al. (2022) demonstrate that LOAD patient tissue containing hp-tau aggregates presents in-vivo human and mouse microglial dystrophy, ferritin enrichment, and increased transcriptomic senescence markers dependent on exacerbated Type I IFN signaling.","journal-title":"Cell Stem Cell"},{"key":"37304_CR71","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337\u2013351 (2007). Yoshiyama et al. (2021) provide evidence in PS19-tauopathy mice that microglial reactivity and synaptic loss precede NFT formation, which complements our hypothesis that maladaptive microglial responses and senescence buildup are required to advance significant hp-tau pathology and spread leading into LOAD progression.","journal-title":"Neuron"},{"key":"37304_CR72","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy, E. R. et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J. Clin. Investig. 130, 1912 (2020). Supporting our hypothesis that state \u201cB\u201d senescent microglia create neuritic plaques and lead to LOAD progression, Roy et al. (2020) provide evidence that microglia with increased type I IFN signaling also contribute to exacerbated synaptic loss, surround amyloid plaques, mediate inflammation in the presence of Ab pathology buildup, and correlate with LOAD disease severity.","journal-title":"J. Clin. Investig."},{"key":"37304_CR73","doi-asserted-by":"crossref","unstructured":"Roy, E. R. et al. Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid \u03b2 plaques. Immunity 55, 879\u2013894.e6 (2022).","DOI":"10.1016\/j.immuni.2022.03.018"},{"key":"37304_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81304-6","volume":"11","author":"J Shin","year":"2021","unstructured":"Shin, J., Park, S., Lee, H. & Kim, Y. Thioflavin-positive tau aggregates complicating quantification of amyloid plaques in the brain of 5XFAD transgenic mouse model. Sci. Rep. 11, 1617 (2021).","journal-title":"Sci. Rep."},{"key":"37304_CR75","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.celrep.2018.07.072","volume":"24","author":"J Brelstaff","year":"2018","unstructured":"Brelstaff, J., Tolkovsky, A. M., Ghetti, B., Goedert, M. & Spillantini, M. G. Living neurons with tau filaments aberrantly expose phosphatidylserine and are phagocytosed by microglia. Cell Rep 24, 1939 (2018).","journal-title":"Cell Rep"},{"key":"37304_CR76","doi-asserted-by":"publisher","first-page":"e14940","DOI":"10.1111\/jnc.14940","volume":"154","author":"K Pampuscenko","year":"2020","unstructured":"Pampuscenko, K. et al. Extracellular tau induces microglial phagocytosis of living neurons in cell cultures. J. Neurochem. 154, e14940 (2020).","journal-title":"J. Neurochem."},{"key":"37304_CR77","doi-asserted-by":"crossref","unstructured":"Brelstaff, J. H. et al. Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates. Sci. Adv. 7, eabg4980 (2021). Brelstaff et al. (2021) demonstrate that human hp-tau aggregates induce lysosomal dysfunction (via SA-b-gal staining) and senescence in mouse microglia, by phagoptosing neurons with hp-tau (further leaving reduced clearance of these neurons with hp-tau) or uptaking hp-tau secretions from senescent microglia.","DOI":"10.1126\/sciadv.abg4980"},{"key":"37304_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1309-z","volume":"15","author":"SC Hopp","year":"2018","unstructured":"Hopp, S. C. et al. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer\u2019s disease. J. Neuroinflammation 15, 269 (2018).","journal-title":"J. Neuroinflammation"},{"key":"37304_CR79","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"I-C Stancu","year":"2019","unstructured":"Stancu, I.-C. et al. Aggregated Tau activates NLRP3\u2013ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol. 137, 599 (2019).","journal-title":"Acta Neuropathol."},{"key":"37304_CR80","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13024-021-00440-9","volume":"16","author":"K Clayton","year":"2021","unstructured":"Clayton, K. et al. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model. Mol. Neurodegener. 16, 18 (2021).","journal-title":"Mol. Neurodegener."},{"key":"37304_CR81","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang, Q. et al. ApoE promotes the proteolytic degradation of A\u03b2. Neuron 58, 681 (2008).","journal-title":"Neuron"},{"key":"37304_CR82","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"37304_CR83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","volume":"13","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju, S. et al. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u2019s disease. Mol. Neurodegener. 13, 24 (2018).","journal-title":"Mol. Neurodegener."},{"key":"37304_CR84","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent, A. A. et al. TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron 105, 837\u2013854.e9 (2020).","journal-title":"Neuron"},{"key":"37304_CR85","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1007\/s12035-017-0757-2","volume":"55","author":"V Theendakara","year":"2018","unstructured":"Theendakara, V., Peters-Libeu, C. A., Bredesen, D. E. & Rao, R. V. Transcriptional effects of ApoE4: relevance to Alzheimer\u2019s disease. Mol. Neurobiol. 55, 5243\u20135254 (2018).","journal-title":"Mol. Neurobiol."},{"key":"37304_CR86","doi-asserted-by":"crossref","unstructured":"Rohn, T. T. & Moore, Z. D. Nuclear localization of apolipoprotein E4: a new trick for an old protein. Int. J. Neurol. Neurother. 4, 067 (2017).","DOI":"10.23937\/2378-3001\/1410067"},{"key":"37304_CR87","doi-asserted-by":"crossref","unstructured":"Muth, C., Hartmann, A., Sepulveda-Falla, D., Glatzel, M. & Krasemann, S. Phagocytosis of apoptotic cells is specifically upregulated in ApoE4 expressing microglia in vitro. Front. Cell. Neurosci. 13, 181 (2019).","DOI":"10.3389\/fncel.2019.00181"},{"key":"37304_CR88","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/glia.23510","volume":"66","author":"WJ Streit","year":"2018","unstructured":"Streit, W. J. et al. Microglial activation occurs late during preclinical Alzheimer\u2019s disease. Glia 66, 2550\u20132562 (2018). Streit et al. (2018) provide evidence and ideate that ferritin-positive dystrophic microglia can cluster around neuritic plaques in individuals transitioning into dementia, whereby dystrophic microglial appearance and abundance precedes hypertrophic microglial appearance and clustering around neuritic plaques.","journal-title":"Glia"},{"key":"37304_CR89","doi-asserted-by":"publisher","first-page":"109228","DOI":"10.1016\/j.celrep.2021.109228","volume":"35","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. Replicative senescence dictates the emergence of disease-associated microglia and contributes to A\u03b2 pathology. Cell Rep 35, 109228 (2021).","journal-title":"Cell Rep"},{"key":"37304_CR90","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.exger.2015.03.007","volume":"68","author":"J-Z Wang","year":"2015","unstructured":"Wang, J.-Z. & Wang, Z.-H. Senescence may mediate conversion of tau phosphorylation-induced apoptotic escape to neurodegeneration. Exp. Gerontol. 68, 82\u201386 (2015).","journal-title":"Exp. Gerontol."},{"key":"37304_CR91","doi-asserted-by":"crossref","unstructured":"Musi, N. et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell 17, e12840 (2018).","DOI":"10.1111\/acel.12840"},{"key":"37304_CR92","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/j.1474-9726.2012.00870.x","volume":"11","author":"D Jurk","year":"2012","unstructured":"Jurk, D. et al. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 11, 996 (2012).","journal-title":"Aging Cell"},{"key":"37304_CR93","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41593-020-00764-7","volume":"24","author":"K Leng","year":"2021","unstructured":"Leng, K. et al. Molecular characterization of selectively vulnerable neurons in Alzheimer\u2019s disease. Nat. Neurosci. 24, 276\u2013287 (2021).","journal-title":"Nat. Neurosci."},{"key":"37304_CR94","doi-asserted-by":"crossref","unstructured":"Wang, X., Michaelis, E. Selective neuronal vulnerability to oxidative stress in the brain. Front. Aging Neurosci. 2, 12 (2010).","DOI":"10.3389\/fnagi.2010.00012"},{"key":"37304_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah, M. et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat. Commun. 11, 6129 (2020).","journal-title":"Nat. Commun."},{"key":"37304_CR96","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/glia.23592","volume":"67","author":"A Nazmi","year":"2019","unstructured":"Nazmi, A. et al. Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression. Glia 67, 1254 (2019).","journal-title":"Glia"},{"key":"37304_CR97","doi-asserted-by":"crossref","unstructured":"Moore, Z., Mobilio, F., Walker, F. R., Taylor, J. M. & Crack, P. J. Abrogation of type-I interferon signalling alters the microglial response to A\u03b21\u201342. Sci. Rep. 10, 3153 (2020).","DOI":"10.1038\/s41598-020-59917-0"},{"key":"37304_CR98","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00401-020-02200-3","volume":"140","author":"AT Nguyen","year":"2020","unstructured":"Nguyen, A. T. et al. APOE and TREM2 regulate amyloid responsive microglia in Alzheimer\u2019s disease. Acta Neuropathol. 140, 477 (2020).","journal-title":"Acta Neuropathol."},{"key":"37304_CR99","doi-asserted-by":"publisher","unstructured":"Prater, K. et al. Transcriptomically unique endolysosomal and homeostatic microglia populations in Alzheimer\u2019s Disease and aged human brain. https:\/\/www.researchsquare.com\/article\/rs-1836861\/v1 (2022) https:\/\/doi.org\/10.21203\/rs.3.rs-1836861\/v1.","DOI":"10.21203\/rs.3.rs-1836861\/v1"},{"key":"37304_CR100","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","volume":"118","author":"WJ Streit","year":"2009","unstructured":"Streit, W. J., Braak, H., Xue, Q.-S. & Bechmann, I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol. 118, 475 (2009). Streit et al. (2009) provide evidence that in patients with LOAD, dystrophic microglial appearance precedes significant neurofibrillary pathology and further correlates with hp-tau aggregate burden and Braak Staging underlying LOAD progression.","journal-title":"Acta Neuropathol."},{"key":"37304_CR101","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0006-8993(91)90783-R","volume":"558","author":"P Cras","year":"1991","unstructured":"Cras, P., Kawai, M., Siedlak, S. & Perry, G. Microglia are associated with the extracellular neurofibrillary tangles of Alzheimer disease. Brain Res. 558, 312\u2013314 (1991).","journal-title":"Brain Res."},{"key":"37304_CR102","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/glia.23782","volume":"68","author":"WJ Streit","year":"2020","unstructured":"Streit, W. J., Khoshbouei, H. & Bechmann, I. Dystrophic microglia in late-onset Alzheimer\u2019s disease. Glia 68, 845\u2013854 (2020).","journal-title":"Glia"},{"key":"37304_CR103","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1021\/acschemneuro.8b00334","volume":"9","author":"DM Angelova","year":"2018","unstructured":"Angelova, D. M. & Brown, D. R. Altered processing of \u03b2-amyloid in SH-SY5Y cells induced by model senescent microglia. ACS Chem. Neurosci. 9, 3137\u20133152 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"37304_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01907-0","volume":"17","author":"IOC Woollacott","year":"2020","unstructured":"Woollacott, I. O. C. et al. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration. J. Neuroinflammation 17, 234 (2020).","journal-title":"J. Neuroinflammation"},{"key":"37304_CR105","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2020.12.003","volume":"99","author":"RK Shahidehpour","year":"2021","unstructured":"Shahidehpour, R. K. et al. Dystrophic microglia are associated with neurodegenerative disease and not healthy aging in the human brain. Neurobiol. Aging 99, 19\u201327 (2021).","journal-title":"Neurobiol. Aging"},{"key":"37304_CR106","doi-asserted-by":"publisher","unstructured":"Paasila, P. J., Davies, D. S., Sutherland, G. T. & Goldsbury, C. Clustering of activated microglia occurs before the formation of dystrophic neurites in the evolution of A\u03b2 plaques in Alzheimer\u2019s disease. Free Neuropathol. 1, https:\/\/doi.org\/10.17879\/freeneuropathology-2020-2845 (2020).","DOI":"10.17879\/freeneuropathology-2020-2845"},{"key":"37304_CR107","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/glia.23804","volume":"68","author":"JD Rodriguez-Callejas","year":"2020","unstructured":"Rodriguez-Callejas, J. D., Fuchs, E. & Perez-Cruz, C. Increased oxidative stress, hyperphosphorylation of tau, and dystrophic microglia in the hippocampus of aged Tupaia belangeri. Glia 68, 1775\u20131793 (2020).","journal-title":"Glia"},{"key":"37304_CR108","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s40478-020-01047-9","volume":"8","author":"MEV Swanson","year":"2020","unstructured":"Swanson, M. E. V. et al. Identification of a dysfunctional microglial population in human Alzheimer\u2019s disease cortex using novel single-cell histology image analysis. Acta Neuropathol. Commun. 8, 170 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"37304_CR109","doi-asserted-by":"publisher","first-page":"e22956","DOI":"10.1002\/ajp.22956","volume":"81","author":"J Rodr\u00edguez-Callejas","year":"2019","unstructured":"Rodr\u00edguez-Callejas, J. et al. Loss of ferritin-positive microglia relates to increased iron, RNA oxidation, and dystrophic microglia in the brains of aged male marmosets. Am. J. Primatol. 81, e22956 (2019).","journal-title":"Am. J. Primatol."},{"key":"37304_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004010050664","volume":"94","author":"JG Sheng","year":"1997","unstructured":"Sheng, J. G., Mrak, R. E. & Griffin, W. S. Neuritic plaque evolution in Alzheimer\u2019s disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. 94, 1\u20135 (1997). Sheng, Mrak, & Griffin (1997) conclude that earlier disease progression in patients with LOAD initially features slightly enlarged and \u201cprimed\u201d microglia, and extremely hypertrophic, plaque-associated microglia surrounding neuritic plaques later in disease progression.","journal-title":"Acta Neuropathol."},{"key":"37304_CR111","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/glia.20678","volume":"56","author":"KO Lopes","year":"2008","unstructured":"Lopes, K. O., Sparks, D. L. & Streit, W. J. Microglial dystrophy in the aged and Alzheimer\u2019s disease brain is associated with ferritin immunoreactivity. Glia 56, 1048\u20131060 (2008).","journal-title":"Glia"},{"key":"37304_CR112","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40478-021-01126-5","volume":"9","author":"B Kenkhuis","year":"2021","unstructured":"Kenkhuis, B. et al. Iron loading is a prominent feature of activated microglia in Alzheimer\u2019s disease patients. Acta Neuropathol. Commun. 9, 27 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"37304_CR113","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/bpa.12704","volume":"29","author":"A McIntosh","year":"2019","unstructured":"McIntosh, A. et al. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP\/PS1 mice. Brain Pathol. 29, 606 (2019).","journal-title":"Brain Pathol."},{"key":"37304_CR114","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neurobiolaging.2020.01.003","volume":"89","author":"L van Olst","year":"2020","unstructured":"van Olst, L. et al. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model. Neurobiol. Aging 89, 89\u201398 (2020).","journal-title":"Neurobiol. Aging"},{"key":"37304_CR115","doi-asserted-by":"publisher","first-page":"110262","DOI":"10.1016\/j.celrep.2021.110262","volume":"38","author":"YH Qureshi","year":"2022","unstructured":"Qureshi, Y. H. et al. The neuronal retromer can regulate both neuronal and microglial phenotypes of Alzheimer\u2019s disease. Cell Rep. 38, 110262 (2022).","journal-title":"Cell Rep."},{"key":"37304_CR116","doi-asserted-by":"publisher","first-page":"eaba6334","DOI":"10.1126\/scitranslmed.aba6334","volume":"12","author":"S Simoes","year":"2020","unstructured":"Simoes, S. et al. Tau and other proteins found in Alzheimer\u2019s disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans. Sci. Transl. Med. 12, eaba6334 (2020).","journal-title":"Sci. Transl. Med."},{"key":"37304_CR117","doi-asserted-by":"crossref","unstructured":"Neumann, P., Lenz, D. E., Streit, W. J. & Bechmann, I. Is microglial dystrophy a form of cellular senescence? An analysis of senescence markers in the aged human brain. Glia 71, 377\u2013390 (2023).","DOI":"10.1002\/glia.24282"},{"key":"37304_CR118","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1002\/glia.23024","volume":"64","author":"J Tischer","year":"2016","unstructured":"Tischer, J. et al. Inhomogeneous distribution of Iba-1 characterizes microglial pathology in Alzheimer\u2019s disease. Glia 64, 1562\u20131572 (2016).","journal-title":"Glia"},{"key":"37304_CR119","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/glia.22966","volume":"64","author":"K Bisht","year":"2016","unstructured":"Bisht, K. et al. Dark microglia: a new phenotype predominantly associated with pathological states. Glia 64, 826\u2013839 (2016).","journal-title":"Glia"},{"key":"37304_CR120","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.neurobiolaging.2015.10.012","volume":"37","author":"EJ Mufson","year":"2016","unstructured":"Mufson, E. J., Malek-Ahmadi, M., Perez, S. E. & Chen, K. Braak staging, plaque pathology and APOE status in elderly persons without cognitive impairment. Neurobiol. Aging 37, 147 (2016).","journal-title":"Neurobiol. Aging"},{"key":"37304_CR121","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He, Z. et al. Amyloid-\u03b2 plaques enhance Alzheimer\u2019s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat. Med. 24, 29\u201338 (2018). He et al. (2018) demonstrate that neuritic plaque abundance precedes significant NFT appearance in both patients with LOAD and 5xFAD A\u03b2-overexpressing mice, and that hp-tau from neuritic plaques seeds further hp-tau pathology earlier and faster than neuron-derived NFTs in 5xFAD mice.","journal-title":"Nat. Med."},{"key":"37304_CR122","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna, J. et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol. Neurodegener. 13, 11 (2018).","journal-title":"Mol. Neurodegener."},{"key":"37304_CR123","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/0197-4580(95)00092-S","volume":"16","author":"IR Mackenzie","year":"1995","unstructured":"Mackenzie, I. R., Hao, C. & Munoz, D. G. Role of microglia in senile plaque formation. Neurobiol. Aging 16, 797\u2013804 (1995).","journal-title":"Neurobiol. Aging"},{"key":"37304_CR124","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/glia.23746","volume":"68","author":"LM Healy","year":"2020","unstructured":"Healy, L. M., Yaqubi, M., Ludwin, S. & Antel, J. P. Species differences in immune-mediated CNS tissue injury and repair: a (neuro)inflammatory topic. Glia 68, 811\u2013829 (2020).","journal-title":"Glia"},{"key":"37304_CR125","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak, H. & Braak, E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging 18, 351\u2013357 (1997).","journal-title":"Neurobiol. Aging"},{"key":"37304_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29552-6","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Microglial NF-\u03baB drives tau spreading and toxicity in a mouse model of tauopathy. Nat. Commun. 13, 1969 (2022).","journal-title":"Nat. Commun."},{"key":"37304_CR127","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai, H. et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18, 1584 (2015).","journal-title":"Nat. Neurosci."},{"key":"37304_CR128","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-016-0143-y","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. The release and trans-synaptic transmission of Tau via exosomes. Mol. Neurodegener. 12, 5 (2017).","journal-title":"Mol. Neurodegener."},{"key":"37304_CR129","doi-asserted-by":"publisher","first-page":"e9027","DOI":"10.15252\/emmm.201809027","volume":"10","author":"CB Lessard","year":"2018","unstructured":"Lessard, C. B. et al. High-affinity interactions and signal transduction between A\u03b2 oligomers and TREM2. EMBO Mol. Med. 10, e9027 (2018).","journal-title":"EMBO Mol. Med."},{"key":"37304_CR130","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3233\/JAD-141704","volume":"44","author":"S Rangaraju","year":"2015","unstructured":"Rangaraju, S., Gearing, M., Jin, L.-W. & Levey, A. Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer\u2019s disease. J. Alzheimers Dis. 44, 797 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"37304_CR131","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2017.03.021","volume":"55","author":"Z Yin","year":"2017","unstructured":"Yin, Z. et al. Immune hyperreactivity of A\u03b2 plaque-associated microglia in Alzheimer\u2019s disease. Neurobiol. Aging 55, 115\u2013122 (2017).","journal-title":"Neurobiol. Aging"},{"key":"37304_CR132","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1093\/hmg\/ddaa209","volume":"29","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions. Hum. Mol. Genet. 29, 3224\u20133248 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"37304_CR133","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns, C. E. G. et al. TREM2 function impedes tau seeding in neuritic plaques. Nat. Neurosci. 22, 1217\u20131222 (2019).","journal-title":"Nat. Neurosci."},{"key":"37304_CR134","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bpa.12717","volume":"29","author":"PJ Paasila","year":"2019","unstructured":"Paasila, P. J., Davies, D. S., Kril, J. J., Goldsbury, C. & Sutherland, G. T. The relationship between the morphological subtypes of microglia and Alzheimer\u2019s disease neuropathology. Brain Pathol. 29, 726\u2013740 (2019).","journal-title":"Brain Pathol."},{"key":"37304_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg, E. et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model. Nat. Commun. 10, 3758 (2019).","journal-title":"Nat. Commun."},{"key":"37304_CR136","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/NEN.0b013e3181fab558","volume":"69","author":"E Richard","year":"2010","unstructured":"Richard, E. et al. Characteristics of dyshoric capillary cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. 69, 1158\u20131167 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"37304_CR137","doi-asserted-by":"crossref","unstructured":"Meisl, G. et al. In vivo rate-determining steps of tau seed accumulation in Alzheimer\u2019s disease. Sci. Adv. 7, eabh1448.","DOI":"10.1126\/sciadv.abh1448"},{"key":"37304_CR138","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal, T. A. et al. Microglial activation and tau propagate jointly across Braak stages. Nat. Med. 27, 1592\u20131599 (2021).","journal-title":"Nat. Med."},{"key":"37304_CR139","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland, T. K. et al. TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease. Cell 170, 649\u2013663.e13 (2017).","journal-title":"Cell"},{"key":"37304_CR140","doi-asserted-by":"publisher","first-page":"111589","DOI":"10.1016\/j.mad.2021.111589","volume":"200","author":"MM Gonzales","year":"2021","unstructured":"Gonzales, M. M. et al. A geroscience motivated approach to treat Alzheimer\u2019s disease: Senolytics move to clinical trials. Mech. Ageing Dev. 200, 111589 (2021).","journal-title":"Mech. Ageing Dev."},{"key":"37304_CR141","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson, L. J. et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine 47, 446\u2013456 (2019).","journal-title":"EBioMedicine"},{"key":"37304_CR142","doi-asserted-by":"crossref","unstructured":"Sokolova, D., Childs, T. & Hong, S. Insight into the role of phosphatidylserine in complement-mediated synapse loss in Alzheimer\u2019s disease. Fac. Rev. 10, (2021).","DOI":"10.12703\/r\/10-19"},{"key":"37304_CR143","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02595-8","volume":"19","author":"M-K St-Pierre","year":"2022","unstructured":"St-Pierre, M.-K. et al. Ultrastructural characterization of dark microglia during aging in a mouse model of Alzheimer\u2019s disease pathology and in human post-mortem brain samples. J. Neuroinflammation 19, 235 (2022).","journal-title":"J. Neuroinflammation"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37304-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37304-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37304-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T14:03:24Z","timestamp":1679753004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37304-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":143,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37304"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-37304-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,25]]},"assertion":[{"value":"5 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1670"}}